5,0
9 févr. 2016
Employé (anonyme)
Employé (ancien), plus de 8 an(s)
Wageningen
Recommande
Approbation du PDG
Perspective commerciale
Avantages
The C1 technology is one of the best in industry and enzymes had a lot of promise. The sale to DuPont was big win for the employees and technology platform.
Inconvénients
The company was under resourced and did not invest enough in research and development and sales and marketing. There were some good managers, but lack of money made progress difficult.